Nephrocare Health Services Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

- Focus on platform-level ROCE-accretive investments rather than country-level details; currently in 5 countries, aiming for 10-15 countries in 5-10 years. - Growth driven by three levers: 1. Same center growth (increased utilization) 2. Increasing footprint in existing markets (adding new clinics) 3. Market expansion via new countries, M&A, and Public-Private Partnerships (PPP). - Target to open 40-50 clinics annually in India, 10-15 clinics annually in the Philippines, and enter a new international market every 12-18 months. - Network utilization is key; capacity addition is essential since dialysis machines have fixed treatment cycles limiting volume growth without new centers. - International operations contribute around 45% of revenue, reflecting their growing importance in overall growth. - The business expects sustained long-term growth through disciplined capacity addition, new market entries, and leveraging the scalable operating platform.

The provided pages of the Nephrocare Health Services Limited document do not explicitly mention details about the current or expected order book or pending orders. However, some relevant points related to future growth and investments include: - The company anticipates expanding from 5 countries to 10-15 countries over the next 5 to 10 years. - Growth is driven by three levers: same center growth, footprint expansion in existing markets, and market expansion including M&A and PPP. - Saudi Arabia market entry depends on winning a nationwide tender, which will determine the number of clinics established. - The newly incorporated EU subsidiary is exploring potential markets like Kazakhstan but no definitive plans yet. - Planned clinic additions: 40-50 in India annually, 10-15 in the Philippines annually, with new international markets approximately every 12-18 months. No specific order book figures or pending orders are disclosed in the excerpts.